{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:29:37Z","timestamp":1793640577403,"version":"4.5.1"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473531"],"award-info":[{"award-number":["82473531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Excellent Young Scientists Fund of the Natural Science Foundation of Hunan Province","award":["2024JJ4096"],"award-info":[{"award-number":["2024JJ4096"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40257-026-01067-6","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T10:20:15Z","timestamp":1787394015000},"page":"1177-1204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex Hormones in Psoriatic Disease: A Systematic Review"],"prefix":"10.1007","volume":"27","author":[{"given":"Yueqiao","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-8378","authenticated-orcid":false,"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397:1301\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6.","journal-title":"Lancet"},{"key":"1067_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054901","volume":"24","author":"AB Azuaga","year":"2023","unstructured":"Azuaga AB, Ram\u00edrez J, Ca\u00f1ete JD. Psoriatic arthritis: pathogenesis and targeted therapies. Int J Mol Sci. 2023;24:4901. https:\/\/doi.org\/10.3390\/ijms24054901.","journal-title":"Int J Mol Sci"},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/PTT.S323300","volume":"12","author":"P Gisondi","year":"2022","unstructured":"Gisondi P, Bellinato F, Maurelli M, Geat D, Zabotti A, McGonagle D, et al. Reducing the risk of developing psoriatic arthritis in patients with psoriasis. Psoriasis (Auckland). 2022;12:213\u201320. https:\/\/doi.org\/10.2147\/PTT.S323300.","journal-title":"Psoriasis (Auckland)."},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2020.04.139","volume":"84","author":"S Mehrmal","year":"2021","unstructured":"Mehrmal S, Uppal P, Nedley N, Giesey RL, Delost GR. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: a systematic analysis from the Global Burden of Disease Study 2017. J Am Acad Dermatol. 2021;84:46\u201352. https:\/\/doi.org\/10.1016\/j.jaad.2020.04.139.","journal-title":"J Am Acad Dermatol"},{"key":"1067_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000112","volume":"9","author":"A Gonzalez-Cantero","year":"2023","unstructured":"Gonzalez-Cantero A, Constantin MM, Dattola A, Hillary T, Kleyn E, Magnolo N. Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists. Int J Womens Dermatol. 2023;9:e112. https:\/\/doi.org\/10.1097\/JW9.0000000000000112.","journal-title":"Int J Womens Dermatol"},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/jdv.20256","volume":"39","author":"S Preis","year":"2025","unstructured":"Preis S, Ziehfreund S, Biedermann T, Horster S, Zink A. A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: is it time for new guidelines? J Eur Acad Dermatol Venereol. 2025;39:512\u201328. https:\/\/doi.org\/10.1111\/jdv.20256.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/jcm14020582","volume":"14","author":"F Cassalia","year":"2025","unstructured":"Cassalia F, Lunardon A, Frattin G, Danese A, Caroppo F, Fortina AB. How hormonal balance changes lives in women with psoriasis. J Clin Med. 2025;14:582. https:\/\/doi.org\/10.3390\/jcm14020582.","journal-title":"J Clin Med"},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jid.2023.11.010","volume":"144","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Yi Y, Jing D, Yang S, Guo Y, Xiao H, et al. Age at natural menopause, reproductive lifespan, and the risk of late-onset psoriasis and psoriatic arthritis in women: a prospective cohort study. J Investig Dermatol. 2024;144:1273-1281.e5. https:\/\/doi.org\/10.1016\/j.jid.2023.11.010.","journal-title":"J Investig Dermatol"},{"key":"1067_CR9","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/art.41787","volume":"73","author":"SA Ramanujan","year":"2021","unstructured":"Ramanujan SA, Cravens EN, Krishfield SM, Kyttaris VC, Moulton VR. Estrogen-induced hsa-miR-10b-5p is elevated in t cells from patients with systemic lupus erythematosus and down-regulates serine\/arginine-rich splicing factor 1. Arthritis Rheumatol. 2021;73:2052\u20138. https:\/\/doi.org\/10.1002\/art.41787.","journal-title":"Arthritis Rheumatol"},{"key":"1067_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41582-024-01042-x","volume":"21","author":"C Nesbitt","year":"2025","unstructured":"Nesbitt C, Van Der Walt A, Butzkueven H, Cheung AS, Jokubaitis VG. Exploring the role of sex hormones and gender diversity in multiple sclerosis. Nat Rev Neurol. 2025;21:48\u201362. https:\/\/doi.org\/10.1038\/s41582-024-01042-x.","journal-title":"Nat Rev Neurol"},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrrheum.2014.144","volume":"10","author":"GC Hughes","year":"2014","unstructured":"Hughes GC, Choubey D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat Rev Rheumatol. 2014;10:740\u201351. https:\/\/doi.org\/10.1038\/nrrheum.2014.144.","journal-title":"Nat Rev Rheumatol"},{"key":"1067_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biom12091299","volume":"12","author":"TA Fedotcheva","year":"2022","unstructured":"Fedotcheva TA, Fedotcheva NI, Shimanovsky NL. Progesterone as an anti-inflammatory drug and immunomodulator: new aspects in hormonal regulation of the inflammation. Biomolecules. 2022;12:1299. https:\/\/doi.org\/10.3390\/biom12091299.","journal-title":"Biomolecules"},{"key":"1067_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2004.10.011","volume":"38","author":"N Kanda","year":"2005","unstructured":"Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005;38:1\u20137. https:\/\/doi.org\/10.1016\/j.jdermsci.2004.10.011.","journal-title":"J Dermatol Sci"},{"key":"1067_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","volume":"294","author":"S Kovats","year":"2015","unstructured":"Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol. 2015;294:63\u20139. https:\/\/doi.org\/10.1016\/j.cellimm.2015.01.018.","journal-title":"Cell Immunol"},{"key":"1067_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","volume":"90","author":"I Paterni","year":"2014","unstructured":"Paterni I, Granchi C, Katzenellenbogen JA, Minutolo F. Estrogen receptors alpha (ER\u03b1) and beta (ER\u03b2): subtype-selective ligands and clinical potential. Steroids. 2014;90:13\u201329. https:\/\/doi.org\/10.1016\/j.steroids.2014.06.012.","journal-title":"Steroids"},{"key":"1067_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01356","volume":"11","author":"S Pace","year":"2020","unstructured":"Pace S, Werz O. Impact of androgens on inflammation-related lipid mediator biosynthesis in innate immune cells. Front Immunol. 2020;11:1356. https:\/\/doi.org\/10.3389\/fimmu.2020.01356.","journal-title":"Front Immunol"},{"key":"1067_CR17","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.3390\/ijms25137100","volume":"25","author":"EA Langan","year":"2024","unstructured":"Langan EA. Prolactin: a mammalian stress hormone and its role in cutaneous pathophysiology. Int J Mol Sci. 2024;25:7100. https:\/\/doi.org\/10.3390\/ijms25137100.","journal-title":"Int J Mol Sci"},{"key":"1067_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1067_CR19","unstructured":"Joanna Briggs Institute. Critical appraisal tools. https:\/\/jbi.global\/critical-appraisal-tools. Accessed 18 Mar 2026."},{"key":"1067_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcreu.2024.12.001","author":"RR Ghamyes","year":"2025","unstructured":"Ghamyes RR, Alkazaz AA. Pathological significance of sex hormones (testosterone and estrogen) associated with pro-inflammatory cytokines (IL-12, IL-17A, and IL-23) in patients with psoriasis and psoriatic arthritis. Revista Colombiana de Reumatolog\u00eda. 2025. https:\/\/doi.org\/10.1016\/j.rcreu.2024.12.001.","journal-title":"Revista Colombiana de Reumatolog\u00eda."},{"key":"1067_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-025-03809-8","volume":"317","author":"RK Das","year":"2025","unstructured":"Das RK, Taylor DL. Association between serum sex steroid hormone concentrations and psoriasis: data from the national health and nutrition examination survey. Arch Dermatol Res. 2025;317:254. https:\/\/doi.org\/10.1007\/s00403-025-03809-8.","journal-title":"Arch Dermatol Res"},{"key":"1067_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/jpm11090925","volume":"11","author":"V Sobolev","year":"2021","unstructured":"Sobolev V, Soboleva A, Denisova E, Denieva M, Dvoryankova E, Suleymanov E, et al. Differential expression of estrogen-responsive genes in women with psoriasis. J Pers Med. 2021;11:925. https:\/\/doi.org\/10.3390\/jpm11090925.","journal-title":"J Pers Med."},{"key":"1067_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archderm.141.5.601","volume":"141","author":"JE Murase","year":"2005","unstructured":"Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol. 2005;141:601\u20136. https:\/\/doi.org\/10.1001\/archderm.141.5.601.","journal-title":"Arch Dermatol"},{"issue":"4","key":"1067_CR24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jaad.2025.06.064","volume":"93","author":"C Zhang","year":"2025","unstructured":"Zhang C, Dai X, Yin Z. Association between psoriasis and estrogen: a population-based study. J Am Acad Dermatol. 2025;93(4):1141\u20131143.\u00a0https:\/\/doi.org\/10.1016\/j.jaad.2025.06.064.","journal-title":"J Am Acad Dermatol"},{"key":"1067_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tjog.2018.02.010","volume":"57","author":"BT Ayanoglu","year":"2018","unstructured":"Ayanoglu BT, Ozdemir ED, Turkoglu O, Alhan A. Diminished ovarian reserve in patients with psoriasis. Taiwan J Obstet Gynecol. 2018;57:227\u201330. https:\/\/doi.org\/10.1016\/j.tjog.2018.02.010.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1067_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jaad.2025.10.059","volume":"94","author":"AS Podolsky","year":"2026","unstructured":"Podolsky AS, Singal A, Lipner SR. Negative association of psoriasis with female sex hormone levels: a case\u2013control study using TriNetX. J Am Acad Dermatol. 2026;94:695\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2025.10.059.","journal-title":"J Am Acad Dermatol"},{"key":"1067_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40257-025-00994-0","volume":"27","author":"K Roster","year":"2026","unstructured":"Roster K, Fleshner L, Karatas TB, Ecanow A, Sayegh A, Farabi B, et al. Menopause and common dermatoses: a systematic review. Am J Clin Dermatol. 2026;27:67\u201384. https:\/\/doi.org\/10.1007\/s40257-025-00994-0.","journal-title":"Am J Clin Dermatol"},{"key":"1067_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/571912","volume":"2013","author":"R Ceovic","year":"2013","unstructured":"Ceovic R, Mance M, Bukvic Mokos Z, Svetec M, Kostovic K, Stulhofer BD. Psoriasis: female skin changes in various hormonal stages throughout life\u2014puberty, pregnancy, and menopause. Biomed Res Int. 2013;2013:571912. https:\/\/doi.org\/10.1155\/2013\/571912.","journal-title":"Biomed Res Int"},{"key":"1067_CR29","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jaad.2021.12.014","volume":"87","author":"D Bello","year":"2022","unstructured":"Bello D, Maurelli M, Schena D, Gisondi P, Girolomoni G. Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle. J Am Acad Dermatol. 2022;87:892\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2021.12.014.","journal-title":"J Am Acad Dermatol"},{"key":"1067_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2340\/00015555-2312","volume":"96","author":"S Wu","year":"2016","unstructured":"Wu S, Cho E, Li W, Grodstein F, Qureshi AA. Hormonal factors and risk of psoriasis in women: a cohort study. Acta Derm Venereol. 2016;96:927\u201331. https:\/\/doi.org\/10.2340\/00015555-2312.","journal-title":"Acta Derm Venereol"},{"key":"1067_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-4362.1996.tb01632.x","volume":"35","author":"AS Boyd","year":"1996","unstructured":"Boyd AS, Morris LF, Phillips CM, Menter MA. Psoriasis and pregnancy: hormone and immune system interaction. Int J Dermatol. 1996;35:169\u201372. https:\/\/doi.org\/10.1111\/j.1365-4362.1996.tb01632.x.","journal-title":"Int J Dermatol"},{"key":"1067_CR32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.semarthrit.2017.01.002","volume":"46","author":"A Polachek","year":"2017","unstructured":"Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum. 2017;46:740\u20135. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.01.002.","journal-title":"Semin Arthritis Rheum"},{"key":"1067_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/03009748809098763","volume":"17","author":"M Ostensen","year":"1988","unstructured":"Ostensen M. Pregnancy in psoriatic arthritis. Scand J Rheumatol. 1988;17:67\u201370. https:\/\/doi.org\/10.3109\/03009748809098763.","journal-title":"Scand J Rheumatol"},{"key":"1067_CR34","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3899\/jrheum.171218","volume":"45","author":"M Berman","year":"2018","unstructured":"Berman M, Zisman D, Wollman J, Levartovsky D, Rimon E, Elkayam O, et al. The effect of pregnancy on disease activity in patients with psoriatic arthritis. J Rheumatol. 2018;45:1651\u20135. https:\/\/doi.org\/10.3899\/jrheum.171218.","journal-title":"J Rheumatol"},{"key":"1067_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/28.1.50","volume":"28","author":"NJ McHugh","year":"1989","unstructured":"McHugh NJ, Laurent MR. The effect of pregnancy on the onset of psoriatic arthritis. Br J Rheumatol. 1989;28:50\u20132. https:\/\/doi.org\/10.1093\/rheumatology\/28.1.50.","journal-title":"Br J Rheumatol"},{"issue":"1","key":"1067_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1600-0757.2011.00407.x","volume":"61","author":"BJ Edwards","year":"2013","unstructured":"Edwards BJ, Li J. Endocrinology of menopause. Periodontol 2000. 2013; 61(1):177\u2013194. https:\/\/doi.org\/10.1111\/j.1600-0757.2011.00407.x.","journal-title":"Periodontol 2000"},{"key":"1067_CR37","doi-asserted-by":"publisher","first-page":"adv42843","DOI":"10.2340\/actadv.v105.42843","volume":"105","author":"BY Chung","year":"2025","unstructured":"Chung BY, Johnson C, Park JS, Haran K, Smith P, Kranyak A, et al. Patient-reported impact of menopause and hormone replacement therapy on psoriasis. Acta Derm Venereol. 2025;105:adv42843. https:\/\/doi.org\/10.2340\/actadv.v105.42843.","journal-title":"Acta Derm Venereol"},{"key":"1067_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/bjd.20410","volume":"185","author":"AA Chan","year":"2021","unstructured":"Chan AA, Noguti J, Yang CT, Feldman SR, Wallace RB, Shadyab AH, et al. Association between menopausal hormone therapy and incidence of psoriasis: a secondary analysis from the Women\u2019s Health Initiative randomized clinical trials. Br J Dermatol. 2021;185:669\u201371. https:\/\/doi.org\/10.1111\/bjd.20410.","journal-title":"Br J Dermatol"},{"key":"1067_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/bjd\/ljaf222","volume":"193","author":"H Xiao","year":"2025","unstructured":"Xiao H, Ding Y, Shen M, Chen X, Xiao Y. Menopausal age, hormone therapy and risk of psoriasis: a prospective cohort study applying inverse probability of treatment weighting analysis. Br J Dermatol. 2025;193:570\u20132. https:\/\/doi.org\/10.1093\/bjd\/ljaf222.","journal-title":"Br J Dermatol"},{"key":"1067_CR40","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e377","volume":"38","author":"GM Go","year":"2023","unstructured":"Go GM, Oh HJ, Han K, Kim YH, Lee HJ, Lee JH. Hormone replacement therapy and psoriasis risk: a nationwide population-based cohort study. J Korean Med Sci. 2023;38:e377. https:\/\/doi.org\/10.3346\/jkms.2023.38.e377.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"1067_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/bjd\/ljaf179","volume":"193","author":"H-W Yang","year":"2025","unstructured":"Yang H-W, Chen Y-H, To S-Y, Wen Y-L, Kao S, Chen L-H, et al. Hormone therapy and increased risk of psoriasis in reproductive-age and postmenopausal women: a nationwide cohort study and target trial emulation. Br J Dermatol. 2025;193(2):259\u2013266. https:\/\/doi.org\/10.1093\/bjd\/ljaf179.","journal-title":"Br J Dermatol"},{"key":"1067_CR42","doi-asserted-by":"publisher","unstructured":"Tskhakaia I, Gonzalez Moret Y, Palmer A-K, Lema D, Musri MC, Tsibadze N, et al. Contraceptives or hormone replacement therapy and associations with autoimmune conditions: exploring effects of estrogen analog supplementation. ACR Open Rheumatol. 2025;7(1):e11774. https:\/\/doi.org\/10.1002\/acr2.11774.","DOI":"10.1002\/acr2.11774"},{"key":"1067_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/trgh.2021.0104","volume":"8","author":"H Braun","year":"2023","unstructured":"Braun H, Thompson EC, Zhang Q, Tangpricha V, Goodman M, Yeung H. Prevalence of psoriasis and perceived association with hormone therapy in transgender adults. Transgender Health. 2023;8:396\u20139. https:\/\/doi.org\/10.1089\/trgh.2021.0104.","journal-title":"Transgender Health"},{"key":"1067_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jaci.2022.03.028","volume":"150","author":"A Adachi","year":"2022","unstructured":"Adachi A, Honda T, Egawa G, Kanameishi S, Takimoto R, Miyake T, et al. Estradiol suppresses psoriatic inflammation in mice by regulating neutrophil and macrophage functions. J Allergy Clin Immunol. 2022;150:909-919.e8. https:\/\/doi.org\/10.1016\/j.jaci.2022.03.028.","journal-title":"J Allergy Clin Immunol"},{"key":"1067_CR45","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/jat.3988","volume":"40","author":"R Iwano","year":"2020","unstructured":"Iwano R, Iwashita N, Takagi Y, Fukuyama T. Estrogen receptor \u03b1 activation aggravates imiquimod-induced psoriasis-like dermatitis in mice by enhancing dendritic cell interleukin-23 secretion. J Appl Toxicol. 2020;40:1353\u201361. https:\/\/doi.org\/10.1002\/jat.3988.","journal-title":"J Appl Toxicol"},{"key":"1067_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42477-y","volume":"14","author":"X Lu","year":"2023","unstructured":"Lu X, Kuai L, Huang F, Jiang J, Song J, Liu Y, et al. Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1. Nat Commun. 2023;14:6767. https:\/\/doi.org\/10.1038\/s41467-023-42477-y.","journal-title":"Nat Commun"},{"key":"1067_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/exd.14688","volume":"32","author":"K Kobayashi","year":"2023","unstructured":"Kobayashi K, Chikazawa S, Chen Y, Suzuki S, Ichimasu N, Katagiri K. Oestrogen inhibits psoriasis-like dermatitis induced by imiquimod in mice in relation to increased IL-10 producing cells despite elevated expression of IL-22, IL-23, IL-17 mRNA. Exp Dermatol. 2023;32:203\u20139. https:\/\/doi.org\/10.1111\/exd.14688.","journal-title":"Exp Dermatol"},{"key":"1067_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818173","volume":"13","author":"H Wu","year":"2022","unstructured":"Wu H, Zeng L, Ou J, Wang T, Chen Y, Nandakumar KS. Estrogen acts through estrogen receptor-\u03b2 to promote mannan-induced psoriasis-like skin inflammation. Front Immunol. 2022;13:818173. https:\/\/doi.org\/10.3389\/fimmu.2022.818173.","journal-title":"Front Immunol"},{"key":"1067_CR49","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00109-023-02338-z","volume":"101","author":"D Antal","year":"2023","unstructured":"Antal D, P\u00f3r \u00c1, Kov\u00e1cs I, Dull K, P\u00f3liska S, Ujlaki G, et al. PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes. J Mol Med (Berl). 2023;101:987\u201399. https:\/\/doi.org\/10.1007\/s00109-023-02338-z.","journal-title":"J Mol Med (Berl)"},{"key":"1067_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.annonc.2024.10.824","volume":"36","author":"J Kim","year":"2025","unstructured":"Kim J, Munster PN. Estrogens and breast cancer. Ann Oncol. 2025;36:134\u201348. https:\/\/doi.org\/10.1016\/j.annonc.2024.10.824.","journal-title":"Ann Oncol"},{"key":"1067_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108592","volume":"254","author":"J Kielb","year":"2024","unstructured":"Kielb J, Saffak S, Weber J, Baensch L, Shahjerdi K, Celik A, et al. Transformation or replacement\u2014effects of hormone therapy on cardiovascular risk. Pharmacol Ther. 2024;254:108592. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108592.","journal-title":"Pharmacol Ther"},{"key":"1067_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126234","volume":"685","author":"J Guo","year":"2025","unstructured":"Guo J, Zhang L, Li Z, Zhang Y, Yang N, Tang H, et al. A transdermal drug delivery system based on estradiol liposomes enhances the alleviation of psoriatic skin inflammation. Int J Pharm. 2025;685:126234. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126234.","journal-title":"Int J Pharm"},{"key":"1067_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175276","volume":"933","author":"J Tang","year":"2022","unstructured":"Tang J, Liu C, Liu S, Zhou X, Lu J, Li M, et al. Inhibition of JAK1\/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model. Eur J Pharmacol. 2022;933:175276. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175276.","journal-title":"Eur J Pharmacol"},{"key":"1067_CR54","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/s0190-9622(82)70083-0","volume":"6","author":"GB Winton","year":"1982","unstructured":"Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol. 1982;6:977\u201398. https:\/\/doi.org\/10.1016\/s0190-9622(82)70083-0.","journal-title":"J Am Acad Dermatol"},{"key":"1067_CR55","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889\u201395. https:\/\/doi.org\/10.1126\/science.3283939.","journal-title":"Science"},{"key":"1067_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3346\/jkms.2000.15.6.647","volume":"15","author":"S Im","year":"2000","unstructured":"Im S, Lee ES, Kim W, Song J, Kim J, Lee M, et al. Expression of progesterone receptor in human keratinocytes. J Korean Med Sci. 2000;15:647\u201354. https:\/\/doi.org\/10.3346\/jkms.2000.15.6.647.","journal-title":"J Korean Med Sci"},{"key":"1067_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.672168","volume":"12","author":"S Hellberg","year":"2021","unstructured":"Hellberg S, Raffetseder J, Rundquist O, Magnusson R, Papapavlou G, Jenmalm MC, et al. Progesterone dampens immune responses in in vitro activated CD4(+) T cells and affects genes associated with autoimmune diseases that improve during pregnancy. Front Immunol. 2021;12:672168. https:\/\/doi.org\/10.3389\/fimmu.2021.672168.","journal-title":"Front Immunol"},{"key":"1067_CR58","doi-asserted-by":"publisher","first-page":"bnaa003","DOI":"10.1210\/endrev\/bnaa003","volume":"41","author":"KA Mason","year":"2020","unstructured":"Mason KA, Schoelwer MJ, Rogol AD. Androgens during infancy, childhood, and adolescence: physiology and use in clinical practice. Endocr Rev. 2020;41:bnaa003. https:\/\/doi.org\/10.1210\/endrev\/bnaa003.","journal-title":"Endocr Rev"},{"key":"1067_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-7827-4-10","volume":"4","author":"MH McIntyre","year":"2006","unstructured":"McIntyre MH. The use of digit ratios as markers for perinatal androgen action. Reprod Biol Endocrinol. 2006;4:10. https:\/\/doi.org\/10.1186\/1477-7827-4-10.","journal-title":"Reprod Biol Endocrinol"},{"key":"1067_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14213","volume":"33","author":"\u0130 \u00d6zer","year":"2020","unstructured":"\u00d6zer \u0130, Temiz SA, Ataseven A, Dursun R, Uyar M, \u00d6zer M. Is prenatal testosterone-estrogen balance associated with psoriasis? Dermatol Ther. 2020;33:e14213. https:\/\/doi.org\/10.1111\/dth.14213.","journal-title":"Dermatol Ther"},{"key":"1067_CR61","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2147\/CCID.S521594","volume":"18","author":"Y Zhuo","year":"2025","unstructured":"Zhuo Y, Lin L, Dong Q, Ye J. Testosterone deficiency and sleep deprivation as risk factors for psoriasis: insights from the National Health and Nutrition Examination Survey (NHANES) 2011-2014. Clin Cosmet Investig Dermatol. 2025;18:1579\u201391. https:\/\/doi.org\/10.2147\/CCID.S521594.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1067_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.22034\/ijd.2022.352280.1578","volume":"26","author":"Y Nahidi","year":"2023","unstructured":"Nahidi Y, Meibodi NT, Abdolhosseinzadeh F, Izanlu M, Davoodi S. Serum levels of sex hormones in men with chronic plaque psoriasis in comparison with a healthy control group. Iran J Dermatol. 2023;26:103\u201310. https:\/\/doi.org\/10.22034\/ijd.2022.352280.1578.","journal-title":"Iran J Dermatol"},{"key":"1067_CR63","doi-asserted-by":"publisher","DOI":"10.31083\/jomh.2021.075","author":"M Al-Zubi","year":"2022","unstructured":"Al-Zubi M, Seetan K, Jarrar B, Aldebei A, Rubbai Y, Daradkeh S. Evaluation of sex hormone profiles and seminal fluid analysis in psoriatic patients and their correlation with psoriasis severity. J Mens Health. 2022. https:\/\/doi.org\/10.31083\/jomh.2021.075.","journal-title":"J Mens Health"},{"key":"1067_CR64","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.21608\/ejhm.2021.180864","volume":"84","author":"AM Abdelmonem","year":"2021","unstructured":"Abdelmonem AM, Atwa EM, Yosef AESA. Evaluation of serum testosterone level in patients with psoriasis and its correlation to severity of the disease. Egypt J Hosp Med. 2021;84:2103\u20137. https:\/\/doi.org\/10.21608\/ejhm.2021.180864.","journal-title":"Egypt J Hosp Med"},{"key":"1067_CR65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1684\/ejd.2019.3605","volume":"29","author":"J-P Allam","year":"2019","unstructured":"Allam J-P, Bunzek C, Schnell L, Heltzel M, Weckbecker L, Wilsmann-Theis D, et al. Low serum testosterone levels in male psoriasis patients correlate with disease severity. Eur J Dermatol. 2019;29:375\u201382. https:\/\/doi.org\/10.1684\/ejd.2019.3605.","journal-title":"Eur J Dermatol"},{"key":"1067_CR66","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/ijd.14178","volume":"57","author":"AEAI Eltaweel","year":"2018","unstructured":"Eltaweel AEAI, Mustafa AI, El-Shimi OS, Algaod FA. Sex hormones, erectile dysfunction, and psoriasis; a bad friendship! Int J Dermatol. 2018;57:1481\u20134. https:\/\/doi.org\/10.1111\/ijd.14178.","journal-title":"Int J Dermatol"},{"key":"1067_CR67","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000471849","volume":"233","author":"G Caldarola","year":"2017","unstructured":"Caldarola G, Milardi D, Grande G, Quercia A, Baroni S, Morelli R, et al. Untreated psoriasis impairs male fertility: a case\u2013control study. Dermatology. 2017;233:170\u20134. https:\/\/doi.org\/10.1159\/000471849.","journal-title":"Dermatology"},{"key":"1067_CR68","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/1346-8138.12803","volume":"42","author":"BC Cemil","year":"2015","unstructured":"Cemil BC, Cengiz FP, Atas H, Ozturk G, Canpolat F. Sex hormones in male psoriasis patients and their correlation with the Psoriasis Area and Severity Index. J Dermatol. 2015;42:500\u20133. https:\/\/doi.org\/10.1111\/1346-8138.12803.","journal-title":"J Dermatol"},{"key":"1067_CR69","first-page":"813","volume":"28","author":"G Pongratz","year":"2010","unstructured":"Pongratz G, Straub RH, Sch\u00f6lmerich J, Fleck M, H\u00e4rle P. Serum BAFF strongly correlates with PsA activity in male patients only\u2014is there a role for sex hormones? Clin Exp Rheumatol. 2010;28:813\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1067_CR70","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/and.12452","volume":"48","author":"F Saad","year":"2016","unstructured":"Saad F, Haider A, Gooren L. Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy\u2014a series of 15 case reports. Andrologia. 2016;48:341\u20136. https:\/\/doi.org\/10.1111\/and.12452.","journal-title":"Andrologia"},{"key":"1067_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09782-1","volume":"51","author":"\u015e Ba\u015far K\u0131l\u0131\u00e7","year":"2024","unstructured":"Ba\u015far K\u0131l\u0131\u00e7 \u015e, Taheri S, Mehmetbeyo\u011flu Duman E, \u00d6ks\u00fcm Solak E, Y\u0131lmaz \u015e\u00fckranl\u0131 Z, Rassoulzadegan M, et al. Psoriatic skin transcript phenotype: androgen\/estrogen and cortisone\/cortisol imbalance with increasing DNA damage response. Mol Biol Rep. 2024;51:933. https:\/\/doi.org\/10.1007\/s11033-024-09782-1.","journal-title":"Mol Biol Rep"},{"key":"1067_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/eji.70016","volume":"55","author":"A Binayke","year":"2025","unstructured":"Binayke A, Dalal R, Suri C, Dandotiya J, Sadhu S, Kumar Y, et al. Testosterone suppresses IL-17 expression by targeting ROR\u03b3t functions. Eur J Immunol. 2025;55:e70016. https:\/\/doi.org\/10.1002\/eji.70016.","journal-title":"Eur J Immunol"},{"issue":"11","key":"1067_CR73","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1016\/j.jid.2025.04.004","volume":"145","author":"K Mieczkowski","year":"2025","unstructured":"Mieczkowski K, Bakiri L, Griss J, Wagner EF. A sex-specific anti-inflammatory role for p62 in psoriasis-like disease. J Investig Dermatol. 2025;145(11):2763\u20132774.e11. https:\/\/doi.org\/10.1016\/j.jid.2025.04.004.","journal-title":"J Investig Dermatol"},{"key":"1067_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103643","volume":"23","author":"V Borba","year":"2024","unstructured":"Borba V, Carrera-Bastos P, Zandman-Goddard G, Lucia A, Shoenfeld Y. Prolactin\u2019s paradox: friend, foe, or both in immune regulation? Autoimmun Rev. 2024;23:103643. https:\/\/doi.org\/10.1016\/j.autrev.2024.103643.","journal-title":"Autoimmun Rev"},{"key":"1067_CR75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.66344\/jpad.v33i1.2161","volume":"33","author":"S Shehzadi","year":"2023","unstructured":"Shehzadi S, Butt G, Saeed W, Saleem H, Mehmood A, Hussain I. Comparison of mean serum prolactin levels between healthy and psoriatic patients. J Pak Assoc Dermatol. 2023;33:78\u201383.","journal-title":"J Pak Assoc Dermatol"},{"key":"1067_CR76","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jdds.2015.03.002","volume":"19","author":"NA Elsherif","year":"2015","unstructured":"Elsherif NA, El-Sherif AI, El-Dibany SA. Serum prolactin levels in dermatological diseases: a case\u2013control study. J Dermatol Dermatol Surg. 2015;19:104\u20137. https:\/\/doi.org\/10.1016\/j.jdds.2015.03.002.","journal-title":"J Dermatol Dermatol Surg"},{"key":"1067_CR77","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000017981","volume":"197","author":"AS Giasuddin","year":"1998","unstructured":"Giasuddin AS, El-Sherif AI, El-Ojali SI. Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology. 1998;197:119\u201322. https:\/\/doi.org\/10.1159\/000017981.","journal-title":"Dermatology"},{"key":"1067_CR78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.26574\/maedica.2018.13.1.25","volume":"13","author":"D Botezatu","year":"2018","unstructured":"Botezatu D, Tovaru M, Georgescu S-R, Curici A, Giurcaneanu C. Treatment effects upon prolactin and soluble receptor of interleukin-2 in psoriatic patients. Maedica (Bucur). 2018;13:25\u201333.","journal-title":"Maedica (Bucur)"},{"key":"1067_CR79","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cca.2013.12.021","volume":"429","author":"S Rathika","year":"2014","unstructured":"Rathika S, Rajappa M, Chandrashekar L, Munisamy M, Thappa DM. Effect of treatment on prolactin levels in patients with psoriasis vulgaris. Clin Chim Acta. 2014;429:212\u20134. https:\/\/doi.org\/10.1016\/j.cca.2013.12.021.","journal-title":"Clin Chim Acta"},{"key":"1067_CR80","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4103\/0019-5154.143512","volume":"59","author":"MA Keen","year":"2014","unstructured":"Keen MA, Hassan I. Serum prolactin levels in psoriasis and its association with disease activity: a case\u2013control study. Indian J Dermatol. 2014;59:562\u20136. https:\/\/doi.org\/10.4103\/0019-5154.143512.","journal-title":"Indian J Dermatol"},{"key":"1067_CR81","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.clinbiochem.2011.07.009","volume":"44","author":"H Malligarjunan","year":"2011","unstructured":"Malligarjunan H, Gnanaraj P, Subramanian S, Elango T, Dayalan H. Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem. 2011;44:1209\u201313. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.07.009.","journal-title":"Clin Biochem"},{"key":"1067_CR82","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2230.2010.03871.x","volume":"36","author":"E Dilm\u00e9-Carreras","year":"2011","unstructured":"Dilm\u00e9-Carreras E, Mart\u00edn-Ezquerra G, S\u00e1nchez-Rega\u00f1a M, Umbert-Millet P. Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol. 2011;36:29\u201332. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03871.x.","journal-title":"Clin Exp Dermatol"},{"key":"1067_CR83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.66344\/jpad.v32i1.1797","volume":"32","author":"R Nasim","year":"2022","unstructured":"Nasim R, Sultana A, Khondker L, Faruque MO, Wahab F, Mahmud H, et al. Serum prolactin concentration in psoriatic patients and its relationship with disease activity. J Pak Assoc Dermatol. 2022;32:27\u201333.","journal-title":"J Pak Assoc Dermatol"},{"key":"1067_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/921819","volume":"2013","author":"RM Robati","year":"2013","unstructured":"Robati RM, Toossi P, Rahmati-Roodsari M, Khalilazar S, Abolhasani E, Namazi N, et al. Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment. ScientificWorldJournal. 2013;2013:921819. https:\/\/doi.org\/10.1155\/2013\/921819.","journal-title":"ScientificWorldJournal"},{"key":"1067_CR85","first-page":"6","volume":"18","author":"M Ghiasi","year":"2015","unstructured":"Ghiasi M, Hallaji Z, Narimani SA. Serum prolactin level in psoriasis: is it really higher than in healthy individuals? Iran J Dermatol. 2015;18:6\u20139.","journal-title":"Iran J Dermatol"},{"key":"1067_CR86","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/ced.12657","volume":"40","author":"P Toossi","year":"2015","unstructured":"Toossi P, Sadat Amini SH, Sadat Amini MS, Partovi Kia M, Enamzade R, Kazeminejad A, et al. Assessment of serum levels of osteopontin, selenium and prolactin in patients with psoriasis compared with healthy controls, and their association with psoriasis severity. Clin Exp Dermatol. 2015;40:741\u20136. https:\/\/doi.org\/10.1111\/ced.12657.","journal-title":"Clin Exp Dermatol"},{"key":"1067_CR87","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/586049","volume":"2014","author":"F Handjani","year":"2014","unstructured":"Handjani F, Saki N, Ahrari I, Ebrahimi M, Khorrami MM, Nematollahi P. Serum prolactin levels in psoriasis vulgaris. ISRN Dermatol. 2014;2014:586049. https:\/\/doi.org\/10.1155\/2014\/586049.","journal-title":"ISRN Dermatol."},{"key":"1067_CR88","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1468-3083.2007.02559.x","volume":"22","author":"C Gorpelioglu","year":"2008","unstructured":"Gorpelioglu C, Gungor E, Alli N. Is prolactin involved in etiopathogenesis of psoriasis? J Eur Acad Dermatol Venereol. 2008;22:1135\u20136. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02559.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1067_CR89","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/ijmr.IJMR_814_15","volume":"145","author":"G Khatri","year":"2017","unstructured":"Khatri G, Mahajan VK, Mehta KS, Sharma KK, Bhushan S, Chauhan PS. Serum prolactin levels in patients with psoriasis: results of a pilot study. Indian J Med Res. 2017;145:250\u20132. https:\/\/doi.org\/10.4103\/ijmr.IJMR_814_15.","journal-title":"Indian J Med Res"},{"key":"1067_CR90","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-4632.2010.04752.x","volume":"50","author":"EA El-Khateeb","year":"2011","unstructured":"El-Khateeb EA, Zuel-Fakkar NM, Eid SM, Abdul-Wahab SE. Prolactin level is significantly elevated in lesional skin of patients with psoriasis. Int J Dermatol. 2011;50:693\u20136. https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04752.x.","journal-title":"Int J Dermatol"},{"key":"1067_CR91","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/exd.13772","volume":"27","author":"H Yang","year":"2018","unstructured":"Yang H, Li X, Xue F, Xia Q, Zhao X, Wang D, et al. Local production of prolactin in lesions may play a pathogenic role in psoriatic patients and imiquimod-induced psoriasis-like mouse model. Exp Dermatol. 2018;27:1245\u201353. https:\/\/doi.org\/10.1111\/exd.13772.","journal-title":"Exp Dermatol"},{"key":"1067_CR92","first-page":"109","volume":"16","author":"G Sasikala","year":"2024","unstructured":"Sasikala G, Vamshidhar I, Itagi AB, Katukuri M, Swapnika T. Histopathological evaluation of tumor necrosis factor-alpha and prolactin in psoriasis. Int J Pharm Clin Res. 2024;16:109\u201314.","journal-title":"Int J Pharm Clin Res"},{"key":"1067_CR93","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3892\/etm.2019.7596","volume":"18","author":"I-I Morar","year":"2019","unstructured":"Morar I-I, Tab\u0103ran F-A, Mocan T, Jianu E-M, Or\u0103san M-S, Pop A-D, et al. Immunohistochemical study of psoriatic plaques and perilesional skin in psoriasis vulgaris patients: a pilot study. Exp Ther Med. 2019;18:888\u201394. https:\/\/doi.org\/10.3892\/etm.2019.7596.","journal-title":"Exp Ther Med"},{"key":"1067_CR94","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/bjd.16116","volume":"178","author":"I Snast","year":"2018","unstructured":"Snast I, Reiter O, Atzmony L, Leshem YA, Hodak E, Mimouni D, et al. Psychological stress and psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2018;178:1044\u201355. https:\/\/doi.org\/10.1111\/bjd.16116.","journal-title":"Br J Dermatol"},{"key":"1067_CR95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/s0190-9622(89)70015-3","volume":"20","author":"RH Seville","year":"1989","unstructured":"Seville RH. Stress and psoriasis: the importance of insight and empathy in prognosis. J Am Acad Dermatol. 1989;20:97\u2013100. https:\/\/doi.org\/10.1016\/s0190-9622(89)70015-3.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1067_CR96","doi-asserted-by":"publisher","first-page":"e09679","DOI":"10.1002\/advs.202509679","volume":"13","author":"Z Li","year":"2026","unstructured":"Li Z, Quan H, Liu W, Chen J, Chu M, Tang X, et al. Stress-induced activation of prolactin-NR4A1-midkine axis exacerbates skin inflammation. Adv Sci. 2026;13(5):e09679. https:\/\/doi.org\/10.1002\/advs.202509679.","journal-title":"Adv Sci"},{"key":"1067_CR97","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/eji.200838852","volume":"39","author":"N Kanda","year":"2009","unstructured":"Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol. 2009;39:996\u20131006. https:\/\/doi.org\/10.1002\/eji.200838852.","journal-title":"Eur J Immunol"},{"key":"1067_CR98","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1210\/en.2006-1639","volume":"148","author":"N Kanda","year":"2007","unstructured":"Kanda N, Watanabe S. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology. 2007;148:2317\u201325. https:\/\/doi.org\/10.1210\/en.2006-1639.","journal-title":"Endocrinology"},{"key":"1067_CR99","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/jdv.12295","volume":"28","author":"CS Hau","year":"2014","unstructured":"Hau CS, Kanda N, Tada Y, Shibata S, Sato S, Watanabe S. Prolactin induces the production of Th17 and Th1 cytokines\/chemokines in murine Imiquimod-induced psoriasiform skin. J Eur Acad Dermatol Venereol. 2014;28:1370\u20139. https:\/\/doi.org\/10.1111\/jdv.12295.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1067_CR100","doi-asserted-by":"publisher","first-page":"562","DOI":"10.5507\/bp.2015.033","volume":"159","author":"M Husakova","year":"2015","unstructured":"Husakova M, Lippert J, Stolfa J, Sedova L, Arenberger P, Lacinova Z, et al. Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgaris. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159:562\u20138. https:\/\/doi.org\/10.5507\/bp.2015.033.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"1067_CR101","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1093\/rheumatology\/kew316","volume":"55","author":"MW Tang","year":"2016","unstructured":"Tang MW, Reedquist KA, Garcia S, Fernandez BM, Codullo V, Vieira-Sousa E, et al. The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatology (Oxford). 2016;55:2248\u201359. https:\/\/doi.org\/10.1093\/rheumatology\/kew316.","journal-title":"Rheumatology (Oxford)"},{"key":"1067_CR102","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1189\/jlb.2A0317-115RR","volume":"102","author":"MW Tang","year":"2017","unstructured":"Tang MW, Garcia S, Malvar Fernandez B, Gerlag DM, Tak P-P, Reedquist KA. Rheumatoid arthritis and psoriatic arthritis synovial fluids stimulate prolactin production by macrophages. J Leukoc Biol. 2017;102:897\u2013904. https:\/\/doi.org\/10.1189\/jlb.2A0317-115RR.","journal-title":"J Leukoc Biol"},{"key":"1067_CR103","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1210\/endrev\/bnac017","volume":"44","author":"B Chakraborty","year":"2023","unstructured":"Chakraborty B, Byemerwa J, Krebs T, Lim F, Chang C-Y, McDonnell DP. Estrogen receptor signaling in the immune system. Endocr Rev. 2023;44:117\u201341. https:\/\/doi.org\/10.1210\/endrev\/bnac017.","journal-title":"Endocr Rev"},{"key":"1067_CR104","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0002-9440(10)65217-0","volume":"155","author":"GS Ashcroft","year":"1999","unstructured":"Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MWJ. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155:1137\u201346. https:\/\/doi.org\/10.1016\/S0002-9440(10)65217-0.","journal-title":"Am J Pathol"},{"key":"1067_CR105","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13555-020-00468-7","volume":"11","author":"ED Lephart","year":"2021","unstructured":"Lephart ED, Naftolin F. Menopause and the skin: old favorites and new innovations in cosmeceuticals for estrogen-deficient skin. Dermatol Ther (Heidelb). 2021;11:53\u201369. https:\/\/doi.org\/10.1007\/s13555-020-00468-7.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1067_CR106","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.maturitas.2017.06.026","volume":"103","author":"HN Wilkinson","year":"2017","unstructured":"Wilkinson HN, Hardman MJ. The role of estrogen in cutaneous ageing and repair. Maturitas. 2017;103:60\u20134. https:\/\/doi.org\/10.1016\/j.maturitas.2017.06.026.","journal-title":"Maturitas"},{"key":"1067_CR107","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrendo.2009.212","volume":"5","author":"M Zitzmann","year":"2009","unstructured":"Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009;5:673\u201381. https:\/\/doi.org\/10.1038\/nrendo.2009.212.","journal-title":"Nat Rev Endocrinol"},{"key":"1067_CR108","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3978\/j.issn.2223-4683.2014.01.04","volume":"3","author":"AG Winter","year":"2014","unstructured":"Winter AG, Zhao F, Lee RK. Androgen deficiency and metabolic syndrome in men. Transl Androl Urol. 2014;3:50\u20138. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2014.01.04.","journal-title":"Transl Androl Urol."},{"key":"1067_CR109","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tem.2010.06.001","volume":"21","author":"EA Langan","year":"2010","unstructured":"Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R. Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab. 2010;21:569\u201377. https:\/\/doi.org\/10.1016\/j.tem.2010.06.001.","journal-title":"Trends Endocrinol Metab"},{"key":"1067_CR110","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/jid.2008.348","volume":"129","author":"K Foitzik","year":"2009","unstructured":"Foitzik K, Langan EA, Paus R. Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Investig Dermatol. 2009;129:1071\u201387. https:\/\/doi.org\/10.1038\/jid.2008.348.","journal-title":"J Investig Dermatol"},{"key":"1067_CR111","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/ijms21020529","volume":"21","author":"K Barab\u00e1s","year":"2020","unstructured":"Barab\u00e1s K, Szab\u00f3-Meleg E, \u00c1brah\u00e1m IM. Effect of inflammation on female gonadotropin-releasing hormone (GnRH) neurons: mechanisms and consequences. Int J Mol Sci. 2020;21:529. https:\/\/doi.org\/10.3390\/ijms21020529.","journal-title":"Int J Mol Sci"},{"key":"1067_CR112","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/endrev\/bnad027","volume":"45","author":"PC Eng","year":"2024","unstructured":"Eng PC, Phylactou M, Qayum A, Woods C, Lee H, Aziz S, et al. Obesity-related hypogonadism in women. Endocr Rev. 2024;45:171\u201389. https:\/\/doi.org\/10.1210\/endrev\/bnad027.","journal-title":"Endocr Rev"},{"key":"1067_CR113","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nrendo.2014.78","volume":"10","author":"KL Gamble","year":"2014","unstructured":"Gamble KL, Berry R, Frank SJ, Young ME. Circadian clock control of endocrine factors. Nat Rev Endocrinol. 2014;10:466\u201375. https:\/\/doi.org\/10.1038\/nrendo.2014.78.","journal-title":"Nat Rev Endocrinol"},{"key":"1067_CR114","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nri1571","volume":"5","author":"R Glaser","year":"2005","unstructured":"Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5:243\u201351. https:\/\/doi.org\/10.1038\/nri1571.","journal-title":"Nat Rev Immunol"},{"key":"1067_CR115","first-page":"929","volume":"3","author":"DL Torre","year":"2007","unstructured":"Torre DL, Falorni A. Pharmacological causes of hyperprolactinemia. Ther Clin Risk Manag. 2007;3:929\u201351.","journal-title":"Ther Clin Risk Manag"},{"key":"1067_CR116","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.4049\/jimmunol.1801403","volume":"202","author":"MA Brown","year":"2019","unstructured":"Brown MA, Su MA. An inconvenient variable: sex hormones and their impact on T cell responses. J Immunol. 2019;202:1927\u201333. https:\/\/doi.org\/10.4049\/jimmunol.1801403.","journal-title":"J Immunol"},{"key":"1067_CR117","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.immuni.2023.10.008","volume":"56","author":"JP Hoffmann","year":"2023","unstructured":"Hoffmann JP, Liu JA, Seddu K, Klein SL. Sex hormone signaling and regulation of immune function. Immunity. 2023;56:2472\u201391. https:\/\/doi.org\/10.1016\/j.immuni.2023.10.008.","journal-title":"Immunity"},{"key":"1067_CR118","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jid.2019.08.437","volume":"139","author":"AC Billi","year":"2019","unstructured":"Billi AC, Gudjonsson JE, Voorhees JJ. Psoriasis: past, present, and future. J Investig Dermatol. 2019;139:e133\u201342. https:\/\/doi.org\/10.1016\/j.jid.2019.08.437.","journal-title":"J Investig Dermatol"},{"key":"1067_CR119","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626\u201338. https:\/\/doi.org\/10.1038\/nri.2016.90.","journal-title":"Nat Rev Immunol"},{"key":"1067_CR120","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323:1945\u201360. https:\/\/doi.org\/10.1001\/jama.2020.4006.","journal-title":"JAMA"},{"key":"1067_CR121","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029\u201372. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.057.","journal-title":"J Am Acad Dermatol"},{"key":"1067_CR122","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1590\/abd1806-4841.20153113","volume":"90","author":"PS Kurizky","year":"2015","unstructured":"Kurizky PS, Ferreira CdeC, Nogueira LSC, Mota LMHda. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding. An Bras Dermatol. 2015;90:367\u201375. https:\/\/doi.org\/10.1590\/abd1806-4841.20153113.","journal-title":"An Bras Dermatol"},{"key":"1067_CR123","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijwd.2016.12.003","volume":"3","author":"ML Porter","year":"2017","unstructured":"Porter ML, Lockwood SJ, Kimball AB. Update on biologic safety for patients with psoriasis during pregnancy. Int J Womens Dermatol. 2017;3:21\u20135. https:\/\/doi.org\/10.1016\/j.ijwd.2016.12.003.","journal-title":"Int J Womens Dermatol"},{"key":"1067_CR124","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijwd.2015.03.001","volume":"1","author":"M Danesh","year":"2015","unstructured":"Danesh M, Murase JE. The immunologic effects of estrogen on psoriasis: a comprehensive review. Int J Womens Dermatol. 2015;1:104\u20137. https:\/\/doi.org\/10.1016\/j.ijwd.2015.03.001.","journal-title":"Int J Womens Dermatol."},{"key":"1067_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020530","volume":"19","author":"M-A Boutet","year":"2018","unstructured":"Boutet M-A, Nerviani A, Gallo Afflitto G, Pitzalis C. Role of the IL-23\/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints. Int J Mol Sci. 2018;19:530. https:\/\/doi.org\/10.3390\/ijms19020530.","journal-title":"Int J Mol Sci"},{"key":"1067_CR126","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nyas.12398","volume":"1317","author":"S Capellino","year":"2014","unstructured":"Capellino S, Straub RH, Cutolo M. Aromatase and regulation of the estrogen-to-androgen ratio in synovial tissue inflammation: common pathway in both sexes. Ann N Y Acad Sci. 2014;1317:24\u201331. https:\/\/doi.org\/10.1111\/nyas.12398.","journal-title":"Ann N Y Acad Sci"},{"key":"1067_CR127","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett G, Lories RJ, D\u2019Agostino M-A, Elewaut D, Kirkham B, Soriano ER, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13:731\u201341. https:\/\/doi.org\/10.1038\/nrrheum.2017.188.","journal-title":"Nat Rev Rheumatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01067-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-026-01067-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01067-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:02:46Z","timestamp":1793638966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-026-01067-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":127,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1007\/s40257-026-01067-6","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.X. serves as a councilor of the International Psoriasis Council (IPC) and has received research support from the International Society for Atopic Dermatitis (ISAD). All other authors report no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Availability of data and material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.X. conceived and supervised the study, secured funding, and critically revised the manuscript. Y.Q.C. and H.X. performed the literature search, study selection, data extraction, quality assessment, evidence synthesis, and drafted the manuscript. Y.L.Z., Z.Y.X., K.H., Z.R.Z., L.Y.H., Y.X.T., M.Y.T., and T.L. assisted with verification of extracted data, preparation of summary tables, interpretation of included studies, and manuscript revision. All authors approved the final version of the manuscript.","order":7,"name":"Ethics","label":"Authors\u2019 contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}